Journal article
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
Abstract
BACKGROUND: Elevated blood pressure and elevated low-density lipoprotein (LDL) cholesterol increase the risk of cardiovascular disease. Lowering both should reduce the risk of cardiovascular events substantially.
METHODS: In a trial with 2-by-2 factorial design, we randomly assigned 12,705 participants at intermediate risk who did not have cardiovascular disease to rosuvastatin (10 mg per day) or placebo and to candesartan (16 mg per day) plus …
Authors
Yusuf S; Lonn E; Pais P; Bosch J; López-Jaramillo P; Zhu J; Xavier D; Avezum A; Leiter LA; Piegas LS
Journal
The New England Journal of Medicine, Vol. 374, No. 21, pp. 2032–2043
Publisher
Massachusetts Medical Society
Publication Date
May 26, 2016
DOI
10.1056/nejmoa1600177
ISSN
0028-4793
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AgedAntihypertensive AgentsBenzimidazolesBiphenyl CompoundsCardiovascular DiseasesCholesterol, LDLDouble-Blind MethodDrug Therapy, CombinationFemaleHumansHydrochlorothiazideHydroxymethylglutaryl-CoA Reductase InhibitorsHypertensionMaleMedication AdherenceMiddle AgedRisk FactorsRosuvastatin CalciumTetrazoles